8:22
Serine & Cysteine Proteases
Serine proteases provide a nice example of rational design of inhibitors based on the cata...
published: 05 Apr 2010
author: Michael Evans
Serine & Cysteine Proteases
Serine & Cysteine Proteases
Serine proteases provide a nice example of rational design of inhibitors based on the catalytic mechanism of an enzyme.- published: 05 Apr 2010
- views: 17226
- author: Michael Evans
4:46
Sarin: A Serine Protease Inhibitor
Sarin is a serine protease inhibitor that forms covalent bonds in the active site of the e...
published: 05 Apr 2010
author: Michael Evans
Sarin: A Serine Protease Inhibitor
Sarin: A Serine Protease Inhibitor
Sarin is a serine protease inhibitor that forms covalent bonds in the active site of the enzyme, preventing catalysis.- published: 05 Apr 2010
- views: 5798
- author: Michael Evans
3:09
GENOME: SERINE PROTEASES
GENOME: SERINE PROTEASES....
published: 15 Nov 2012
author: Walter Jahn
GENOME: SERINE PROTEASES
GENOME: SERINE PROTEASES
GENOME: SERINE PROTEASES.- published: 15 Nov 2012
- views: 225
- author: Walter Jahn
10:50
Chymotrypsin mechanism
For more information, log on to- http://shomusbiology.weebly.com/ Download the study mater...
published: 07 Dec 2012
author: Suman Bhattacharjee
Chymotrypsin mechanism
Chymotrypsin mechanism
For more information, log on to- http://shomusbiology.weebly.com/ Download the study materials here- http://shomusbiology.weebly.com/bio-materials.html In vi...- published: 07 Dec 2012
- views: 2712
- author: Suman Bhattacharjee
47:21
#12 Biochemistry Catalytic Mechanisms I Lecture for Kevin Ahern's BB 450/550
1. Contact me at kgahern@davincipress.com / Friend me on Facebook (kevin.g.ahern) 2. Downl...
published: 22 Oct 2011
author: Kevin Ahern
#12 Biochemistry Catalytic Mechanisms I Lecture for Kevin Ahern's BB 450/550
#12 Biochemistry Catalytic Mechanisms I Lecture for Kevin Ahern's BB 450/550
1. Contact me at kgahern@davincipress.com / Friend me on Facebook (kevin.g.ahern) 2. Download my new free biochemistry book at http://biochem.science.oregons...- published: 22 Oct 2011
- views: 7125
- author: Kevin Ahern
25:52
Serine Protease from Halophiles Gene Cloning and Expression [Benkyoukai PP ON - Saifur Rahman PhD]
Acara sharing keilmuan (benkyoukai) PPI Osaka Nara pada tanggal 10 Maret 2013....
published: 13 Mar 2013
author: Nurmalia Hardady
Serine Protease from Halophiles Gene Cloning and Expression [Benkyoukai PP ON - Saifur Rahman PhD]
Serine Protease from Halophiles Gene Cloning and Expression [Benkyoukai PP ON - Saifur Rahman PhD]
Acara sharing keilmuan (benkyoukai) PPI Osaka Nara pada tanggal 10 Maret 2013.- published: 13 Mar 2013
- views: 48
- author: Nurmalia Hardady
50:29
Catalytic Strategies
This course is part of a series taught by Kevin Ahern at Oregon State University on Genera...
published: 20 Oct 2010
author: Oregon State University
Catalytic Strategies
Catalytic Strategies
This course is part of a series taught by Kevin Ahern at Oregon State University on General Biochemistry. For more information about online courses go to htt...- published: 20 Oct 2010
- views: 8260
- author: Oregon State University
10:24
Chymotrypsin Mechanism of Action Movie
How does chymotrypsin work? Chymotrypsin is an an enzyme. It is a protease, it cuts adja...
published: 21 Oct 2013
Chymotrypsin Mechanism of Action Movie
Chymotrypsin Mechanism of Action Movie
How does chymotrypsin work? Chymotrypsin is an an enzyme. It is a protease, it cuts adjacent to tryptophan, phenylalanine and tyrosine. This video describes the amino acids and the reaction mechanisms involved. I use play dough and molecular models from 3D biosystems and Cochranes of Oxford.- published: 21 Oct 2013
- views: 4
45:52
12. Kevin Ahern's Biochemistry - Enzyme Mechanisms
1. Contact me at kgahern@davincipress.com / Friend me on Facebook (kevin.g.ahern)
2. Downl...
published: 26 Oct 2013
12. Kevin Ahern's Biochemistry - Enzyme Mechanisms
12. Kevin Ahern's Biochemistry - Enzyme Mechanisms
1. Contact me at kgahern@davincipress.com / Friend me on Facebook (kevin.g.ahern) 2. Download my free biochemistry book at http://biochem.science.oregonstate.edu/biochemistry-free-and-easy 3. Take my free iTunes U course at https://itunes.apple.com/us/course/biochemistry/id556410409 4. Check out my free book for pre-meds at http://biochem.science.oregonstate.edu/biochemistry-free-and-easy 5. Course video channel at http://www.youtube.com/user/oharow/videos?view=1 6. Check out all of my free workshops at http://www.youtube.com/playlist?list=PLlnFrNM93wqyTiCLZKehU1Tp8rNmnOWYB&feature;=view_all 7. Check out my Metabolic Melodies at http://www.davincipress.com/metabmelodies.html 8. My courses can be taken for credit (wherever you live) via OSU's ecampus. For details, see http://ecampus.oregonstate.edu/soc/ecatalog/ecourselist.htm?termcode=all&subject;=BB 9. Course materials at http://oregonstate.edu/instruct/bb450Highlights Catalytic Mechanisms 1. In the active site of chymotrypsin (and other serine proteases) is a so-called catalytic triad of amino acids that includes a serine hydrogen bonded to a histidine. The histidine is, in turn, hydrogen bonded to an aspartic acid residue in the active site. Each of the hydrogen bonds of the catalytic triad is important in the catalytic mechanism. The nucleophilic alkoxide ion on serine is made possible ultimately by interactions in the catalytic triad and these hydrogen bonds. 2. The catalytic triad is not unique to chymotrypsin. The serine protease known as subtilisin also has the same catalytic triad and employs a similar mechanism. 3. In catalysis of serine proteases, there are several distinct steps - a) binding of the proper substrate; b) conformational changes that affect the catalytic triad, bringing the histidine closer to the hydroxyl group of serine and extracting its proton to create an alkoxide ion; c) attack by the alkoxide ion onto the carbonyl carbon of the peptide bond, creating an unstable intermediate; d) stabiliziation of the intermediate, which falls apart, breating the peptide bond and causing one side to be covalently attached to the serine side chain, releasing the other side; e) entry of water into the active side; f) activation of water by removal of a proton by histidine; g) attack of the hydroxyl group on the carbonyl carbon attached to serine; h) release of the second peptide and regeneration of the original active site. 4. Besides the catalytic triad, the enzyme has two other important sites to consider. The first is the oxyanion hole that stabilizes a tetrahedral intermediate that arises twice during the catalysis. The second, called as S1 pocket, is where the substrate binds. Both the oxyanion hole and the S1 pocket are adjacent to the active site (catalytic triad). 5. The S1 pocket determines a serine protease's specificity. The S1 pocket of chymotrypsin is hydrophobic and relatively large, allowing it to bind phenylalanine, for example. Remember that chymotrypsin cuts adjacent to phenylalanine (among other hydrophobic amino acids). The S1 pocket of trypsin, for example has a negatively charged group in the bottom, allowing it to bind to lysine or arginine. 6. Other proteases include cysteine proteases, aspartyl proteases, metalloproteases. 7. Aspartyl proteases use two aspartic acid side chains to hold water in place and use an ion of it to act as a nucleophile to attack the peptide bond. 8. Metalloproteases use a metal ion to hold water in place so it can be ionized to act as a nucleophile to attack the peptide bond. 9. Carbonic anhydrase is an enzyme that catalyzes the joining of carbon dioxide and water to form carbonic acid. 10. A zinc ion (held in place by three histidines in the active site of carbonic anhydrase) plays an important role in the catalysis of the enzyme by binding a water molecule. A subsequent loss of a proton by water is necessary for catalysis. Notably, the enzyme has maximal activity at a high pH (where protons are easily removed) and a lower activity in an acidic pH (6.0). 11. The limiting step in the action of carbonic anhydrase is the abstraction of the proton from water. Buffers and/or bases help facilitate this and thus speed the reaction.- published: 26 Oct 2013
- views: 347
8:16
Aspartyl Proteases: Mechanism & Inhibition
Aspartyl proteases use two aspartate side chains to facilitate the cleavage of proteins. I...
published: 05 Apr 2010
author: Michael Evans
Aspartyl Proteases: Mechanism & Inhibition
Aspartyl Proteases: Mechanism & Inhibition
Aspartyl proteases use two aspartate side chains to facilitate the cleavage of proteins. In this webcast we study their mechanism in detail and explore inhib...- published: 05 Apr 2010
- views: 4343
- author: Michael Evans
48:50
11. Kevin Ahern's Biochemistry - Enzymes III
1. Contact me at kgahern@davincipress.com / Friend me on Facebook (kevin.g.ahern)
2. Downl...
published: 24 Oct 2013
11. Kevin Ahern's Biochemistry - Enzymes III
11. Kevin Ahern's Biochemistry - Enzymes III
1. Contact me at kgahern@davincipress.com / Friend me on Facebook (kevin.g.ahern) 2. Download my free biochemistry book at http://biochem.science.oregonstate.edu/biochemistry-free-and-easy 3. Take my free iTunes U course at https://itunes.apple.com/us/course/biochemistry/id556410409 4. Check out my free book for pre-meds at http://biochem.science.oregonstate.edu/biochemistry-free-and-easy 5. Course video channel at http://www.youtube.com/user/oharow/videos?view=1 6. Check out all of my free workshops at http://www.youtube.com/playlist?list=PLlnFrNM93wqyTiCLZKehU1Tp8rNmnOWYB&feature;=view_all 7. Check out my Metabolic Melodies at http://www.davincipress.com/metabmelodies.html 8. My courses can be taken for credit (wherever you live) via OSU's ecampus. For details, see http://ecampus.oregonstate.edu/soc/ecatalog/ecourselist.htm?termcode=all&subject;=BB 9. Course materials at http://oregonstate.edu/instruct/bb450 Highlights of Enzymes III Lecture 1.Chemicals, such as DIPF and iodoacetate, covalently (and irreversibly) bind to the side chains of specific amino acids (serine and cysteine, respectively) and if these side chains are essential for the catalytic action of the enzyme, the enzyme will not catalyze reactions after being treated with these chemicals. 2. Penicillin is a substance that resembles the substrate of an enzyme in bacteria that helps make the bacterial cell wall. When it binds to the enzyme, it inactivates the enzyme by covalently bonding to the active site, thus destroying the enzyme (and killing the bacterium containing it). An inhibitor of this type is known as a suicide inhibitor. Highlights Catalytic Mechanisms 1. Proteases catalyze the hydrolysis of peptide bonds in polypeptides. They are usually fairly specific for certain amino acids and cut at or near those amino acids. 2. Chymotrypsin is a protease whose activity has been closely studied. Conveniently, the activity of chymotrypsin can be studied using an artificial substrate which, when cleaved by the enzyme, releases a yellow product. 3. When the release of the colored substrate by the enzyme is studied, it appears to occur in two different rates. First there is a VERY rapid release of the colored substrate. After that initial burst of activity, the remaining yellow color is released slowly. 4. The reason appears to be that the reaction catalyzed occurs in two steps. The first step cleaves the bond to produce the yellow product, which is rapidly released. The other product of this reaction is the remainder of the substrate that is covalently linked to the enzyme. In order for the enzyme to bind another substrate molecule and release more yellow color, it must first release the covalently bound molecule. This step occurs slowly and explains why subsequent yellow molecules are released slowly - after the initial one is released, the enzyme must remove the covalently bound molecule, bind a new substrate, and cut the substrate and the continue the process repeatedly. 5. Chymotrypsin is an example of a protease that employs reactive serine in its active site. Such an enzyme is called a serine protease. Treatment of chymotrypsin with DIPF, which covalently links to serines, inactivates the enzyme. 6. Serine proteases form covalent intermediates with their polypeptide substrates. The first step involves nucleophilic attack of an alkoxide ion on the polypeptide substrate to form an acyl-enzyme intermediate. Formation of this intermediate results in cleavage of the peptide bond and release of the first polypeptide fragment. The acyl-enzyme intermediate is resolved by addition of water to release the other portion of the original polypeptide along with regeneration of the original enzyme active site. This last step occurs relatively slowly. 7. In the active site of chymotrypsin (and other serine proteases) is a so-called catalytic triad of amino acids that includes a serine hydrogen bonded to a histidine. The histidine is, in turn, hydrogen bonded to an aspartic acid residue in the active site. Each of the hydrogen bonds of the catalytic triad is important in the catalytic mechanism. The nucleophilic alkoxide ion on serine is made possible ultimately by interactions in the catalytic triad and these hydrogen bonds.- published: 24 Oct 2013
- views: 195
1:10
OMICS Group reports NS3 Protease inhibitors in HCV infection
The study establishes the degree and form of relationship between HCV infection and the NS...
published: 02 Dec 2013
OMICS Group reports NS3 Protease inhibitors in HCV infection
OMICS Group reports NS3 Protease inhibitors in HCV infection
The study establishes the degree and form of relationship between HCV infection and the NS-3 Serine protease inhibitors in open access article- published: 02 Dec 2013
- views: 3
3:05
Investigation of the Mechanism of Protein Denaturation by Guanidine Hydrochloride
Title: Introduction to Molecular Topology: Basic Concepts and Application to Drug Design
J...
published: 30 Dec 2013
Investigation of the Mechanism of Protein Denaturation by Guanidine Hydrochloride
Investigation of the Mechanism of Protein Denaturation by Guanidine Hydrochloride
Title: Introduction to Molecular Topology: Basic Concepts and Application to Drug Design Journal: Current Computer-Aided Drug Design (CCADD) Author: Dr Jorge Gálvez Issue No: 8, 3 (2012) IMPACT FACTOR: 1.54 Abstract: In this communication we describe an approach in which guanidine hydrochloride-induced dissociation of a protein inhibitor-serine protease complex is used to explore the molecular basis of protein denaturation. The rationale behind this approach is that the inhibitor-protease complex is stabilized by the same types of non-covalent interactions that stabilize the native state of a protein. The dissociation of inhibitor-protease complex can be performed at concentrations of guanidine hydrochloride at which the inhibitor and the protease retain their native conformations. Here, we present our results on the effect of 0.1M to 0.4M guanidine hydrochloride concentrations on the association equilibrium constants (reciprocal of dissociation constant) of P1G, P1A, P1V, P1N, and P1S variants of turkey ovomucoid third domain with bovine α-chymotrypsin. We use these results to calculate the free energy change in the dissociation of inhibitor-protease complexes (the m value) per mol of guanidine hydrochloride concentration. Our results agree with the general consensus that the denaturing effect of guanidine hydrochloride is due to its favorable interaction with the polar parts of proteins and that the non-polar side chains have no or little favorable interaction with guanidine hydrochloride. For more information, please visit: http://www.benthamscience.com/contents.php?in=105825&m;=February&y;=2013- published: 30 Dec 2013
- views: 2
Youtube results:
0:58
A soft model of HIV-1 Protease, in Complex with Vx-478
A soft and transparent handleable protein model
Rev. Sci. Instrum. 83, 084303 (2012); http...
published: 09 Dec 2013
A soft model of HIV-1 Protease, in Complex with Vx-478
A soft model of HIV-1 Protease, in Complex with Vx-478
A soft and transparent handleable protein model Rev. Sci. Instrum. 83, 084303 (2012); http://dx.doi.org/10.1063/1.4739961- published: 09 Dec 2013
- views: 25
2:57
The Role of Serine Residue
Serenade For Strings - Allegro Piacevole-Extreme Music Elgar, Edward Serine & Cysteine Pro...
published: 10 Dec 2012
author: blogchemistry
The Role of Serine Residue
The Role of Serine Residue
Serenade For Strings - Allegro Piacevole-Extreme Music Elgar, Edward Serine & Cysteine Proteases http://www.youtube.com/watch?v=-6WSmDjbuzA.- published: 10 Dec 2012
- views: 34
- author: blogchemistry
50:21
Kevin Ahern's Bite-Sized Biochemistry #12: Catalytic Mechanisms
1. Contact me at kgahern@davincipress.com / Friend me on Facebook (kevin.g.ahern) 2. Downl...
published: 09 Jun 2011
author: Kevin Ahern
Kevin Ahern's Bite-Sized Biochemistry #12: Catalytic Mechanisms
Kevin Ahern's Bite-Sized Biochemistry #12: Catalytic Mechanisms
1. Contact me at kgahern@davincipress.com / Friend me on Facebook (kevin.g.ahern) 2. Download my new free biochemistry book at http://biochem.science.oregons...- published: 09 Jun 2011
- views: 2818
- author: Kevin Ahern
0:36
Launch of Protease Inhibitors (PIs) created a wave in 2011-2012
For the complete report ,visit us at: http://bit.ly/hepatitis-c-virus
Or, get in touch wi...
published: 07 Jan 2014
Launch of Protease Inhibitors (PIs) created a wave in 2011-2012
Launch of Protease Inhibitors (PIs) created a wave in 2011-2012
For the complete report ,visit us at: http://bit.ly/hepatitis-c-virus Or, get in touch with us at : support@researchonglobalmarkets.com Abstract: The launch of Protease inhibitors (PIs) created a wave in 2011-12 and accelerated the pace of innovation and impressive Sustained Virologic Response (SVR) rates by oral IFN free drug combinations have raised the bar and the expectations of pts, physicians and investors. Freedom from IFN, treating all genotypes and betting on vaccines could bring a sea of change in the HCV therapy class area in the future. Roche set the trend with the acquisition of Anadys for total of $230m followed by GILD buying VRUS for $11b, Bristol-Myers Squibb (BMY) acquired Inhibitex for $2.5b, VRTX acquired Virochem in 2009 for $375m + in-licensed Alios VX-135 in 2012 for total of $775m, and Abbott in-licensed Enantas ABT-450 for total of $310m. In the next spurt of M&A; in this sector, we expect companies which offer differentiated MOA to be in the limelight, are (i) Alleviate the need for Ribavarin, (ii) Address resistance, non-responders, Liver cirrhosis, HIV-HCV -co infection etc, (iii) Target other genotypes, and (iv) Vaccines or Boosters of immune system (toll like receptors). In this report, we have analyzed the novel pipeline candidates, which target unmet needs, offer promise of an all oral IFN-free treatment with at par or better efficacy / compliance, and novel vaccine candidates. Table of Contents: 1. Executive Summary 2. Progress in the Clinical Development of HCV drugs Noteworthy progress in the Oral IFN -Free combinations for Treatment of HCV Options for the most Challenging Patient Subtypes in HCV IFN intolerant and other Genotypes Hepatitis C Virus Prevalence in ROW 3. Competitive Landscape - IFN-Free drugs Gilead: Sofosbuvir/GS-5885 Abbott: ABT-450r/ABT-472/ABT-333 Boehringer Ingelheim: Faldaprevir/BI 207127 Medevir: Simeprevir Vertexs VX-135 Bristol-Myers: Daclatasvir/Asunaprevir Merck: MK-5172/MK-8742 4. Market Dynamics- Present and Future Present- Launch of Protease Inhibitors: Sunset Sooner Than Expected. Future- the Best-in-Class IFN-Free Oral Pill for HCV 5. HCV Vaccines GlobeImmune Okairos ChronTech Pharma/ Inovio Transgenes TG4040 Profectus Biosciences HCV vaccine Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden 6. HCV-HIV Co-infection Effects of co-infection Companies targeti ng HIV-HCV Co-infection 7. ANNEXURE Figures - Designs of ongoing IFN-free PhIII trials Table - Data from IFN-free combinations Table - Viral response in genotype-1 patients - IFN-combinations Key Abstract presented at AASLD 12- published: 07 Jan 2014
- views: 0